Robotic Brachytherapy and Sublobar Resection for T1 Non-Small Cell Lung Cancer in High-Risk Patients

被引:6
|
作者
Blasberg, Justin D. [1 ]
Belsley, Scott J.
Schwartz, Gary S.
Evans, Andrew
Wernick, Iddo
Ashton, Robert C., Jr.
Bhora, Faiz Y.
Connery, Cliff P.
机构
[1] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp Ctr, Dept Surg, New York, NY 10023 USA
来源
ANNALS OF THORACIC SURGERY | 2010年 / 89卷 / 02期
关键词
THORACOSCOPIC WEDGE RESECTION; LIMITED RESECTION; I-125; BRACHYTHERAPY; LOBECTOMY; SEGMENTECTOMY; CARCINOMA; PULMONARY; SURVIVAL; IMPLANTATION;
D O I
10.1016/j.athoracsur.2009.09.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Sublobar lung resection and brachytherapy seed placement is gaining acceptance for T1 non-small cell lung cancer (NSCLC) in select patients with comorbidities precluding lobectomy. Our institution first reported utilization of the da Vinci system for robotic brachytherapy developed experimentally in swine and applied to high-risk patients 5 years ago. We now report seed dosimetrics and midterm follow-up. Methods. Eleven high-risk patients with stage IA NSCLC who were not candidates for conventional lobectomy underwent limited resection of 12 primary tumors. To reduce locoregional recurrence, I-125 brachytherapy seeds were robotically sutured intracorporeally over resection margins to deliver 14,400 cGy 1 cm from the implant plane. Patients were followed with dosimetric computed tomography scans at 30 +/- 16 days. Survival and sites of recurrence were documented. Results. Resected tumor size averaged 1.48 +/- 0.38 cm (range, 1.1 to 2.1 cm). Perioperative mortality was 0% and recurrence was 9% (1 of 11 [margin recurrence at 6 months with resultant mortality at 1 year]). Follow-up duration was 31.82 +/- 17.35 months. Dosimetrics confirmed 14,400 cGy delivery using 24.21 +/- 4.6 I-125 seeds (range, 17 to 30 seeds) over a planning target volume of 10.29 +/- 2.39 cc(3). Overall, 84.1% of the planning target volume was covered by 100% of the prescription dose (V100), and 88.2% was covered by 87% of the prescription dose (V87), comparable to open dosimetric data at our institution. Follow-up imaging confirmed seed stability in all patients. Conclusions. Robotic I-125 brachytherapy seed placement is a feasible adjuvant procedure to reduce the incidence of recurrence after sublobar resection in medically compromised patients. Tailored robotic seed placement delivers an exact dosing regimen in a minimally invasive fashion with equivalent precision to open surgery. (Ann Thorac Surg 2010;89:360-7) (C) 2010 by The Society of Thoracic Surgeons
引用
收藏
页码:360 / 367
页数:8
相关论文
共 50 条
  • [1] Identification of Stage I Non-small Cell Lung Cancer Patients at High Risk for Local Recurrence Following Sublobar Resection
    Varlotto, John M.
    Medford-Davis, Laura N.
    Recht, Abram
    Flickinger, John
    Yao, Nengliang
    Hess, Clayton
    Reed, Michael F.
    Toth, Jennifer
    Zander, Dani S.
    DeCamp, Malcolm M.
    CHEST, 2013, 143 (05) : 1365 - 1377
  • [2] Sublobar Resection for Non-Small Cell Lung Cancer in Iceland
    Alexandersson, Asgeir
    Jonsson, Steinn
    Isaksson, Helgi J.
    Guobjartsson, Tomas
    LAEKNABLADID, 2011, 97 (05): : 303 - 308
  • [3] Sublobar Resection with Brachytherapy Mesh for Stage I Non-Small Cell Lung Cancer
    Odell, David D.
    Kent, Michael S.
    Fernando, Hiran C.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2010, 22 (01) : 32 - 37
  • [4] Is Sublobar Resection Feasible for High-Risk Pathologic Stage I Non-small Cell Lung Cancer?
    Akamine, Takaki
    Wakasu, Sho
    Matsubara, Taichi
    Yamaguchi, Masafumi
    Yamazaki, Koji
    Hamatake, Motoharu
    Kometani, Takuro
    Kinoshita, Fumihiko
    Kohno, Mikihiro
    Shimokawa, Mototsugu
    Takenaka, Tomoyoshi
    Yoshizumi, Tomoharu
    ANNALS OF SURGICAL ONCOLOGY, 2024, : 4161 - 4172
  • [5] Robotic Surgery for Non-Small Cell Lung Cancer Treatment in High-Risk Patients
    Zirafa, Carmelina Cristina
    Romano, Gaetano
    Sicolo, Elisa
    Cariello, Claudia
    Morganti, Riccardo
    Conoscenti, Lucia
    Hung-Key, Teresa
    Davini, Federico
    Melfi, Franca
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [6] Sublobar resection in the treatment of elderly patients with early-stage non-small cell lung cancer
    Afonso, Margarida
    Branco, Carlos
    Alfaro, Tiago Manuel
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2020, 46 (04)
  • [7] Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with Stage I non-small-cell lung cancer?
    Mahmood, Sarah
    Bilal, Haris
    Faivre-Finn, Corinne
    Shah, Rajesh
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2013, 17 (05) : 845 - 853
  • [8] Segmentectomy Versus Wedge Resection for Non-Small Cell Lung Cancer in High-Risk Operable Patients
    Kent, Michael
    Landreneau, Rodney
    Mandrekar, Sumithra
    Hillman, Shauna
    Nichols, Francis
    Jones, David
    Starnes, Sandra
    Tan, Angelina
    Putnam, Joe
    Meyers, Brian
    Daly, Benedict
    Fernando, Hiran C.
    ANNALS OF THORACIC SURGERY, 2013, 96 (05): : 1747 - 1755
  • [9] Sublobar resection for stage IA non-small cell lung cancer
    Berfield, Kathleen S.
    Wood, Douglas E.
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S208 - S210
  • [10] Accurate Selection of Sublobar Resection for Small Non-small Cell Lung Cancer
    Motono, Nozomu
    Mizoguchi, Takaki
    Ishikawa, Masahito
    Iwai, Shun
    Iijima, Yoshihito
    Uramoto, Hidetaka
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (02) : 811 - 822